New markers of oxidative stress in lichen planus and the influence of hepatitis C virus infection - a pilot study

被引:1
作者
Mitran, Madalina Irina [1 ]
Tampa, Mircea [1 ,2 ]
Nicolae, Ilinca [2 ]
Mitran, Cristina Iulia [1 ]
Matei, Clara [1 ]
Georgescu, Simona Roxana [1 ,2 ]
Popa, Mircea Ioan [1 ,3 ]
机构
[1] Carol Davila Univ Med & Pharm, 37 Dionisie Lupu, Bucharest 020021, Romania
[2] Victor Babes Clin Hosp Infect Dis, 281 Mihai Bravu, Bucharest 030303, Romania
[3] Cantacuzino Natl Med Mil Inst Res & Dev, 103 Splaiul Independentei, Bucharest 050096, Romania
关键词
oxidative stress; 4-HNE; SDMA; lipid peroxidation; TAC; lichen planus; HCV infection; LIPID-PEROXIDATION; ANTIOXIDANT STATUS; DISEASES; PROTEIN;
D O I
10.2478/rjim-2021-0017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Lichen planus (LP) is a mucocutaneous T-cell mediated disorder of unknown etiology. There is growing evidence that oxidative stress is an important player in the pathogenesis of LP. Therefore, we have investigated oxidative stress markers in LP and the influence of hepatitis C virus (HCV) infection, a frequently associated condition, on oxidative stress in LP patients. Method. We have determined the serum levels of 4- hydroxynonenal (4-HNE) and symmetric dimethylarginine (SDMA), as markers of oxidative stress, and total antioxidant capacity (TAC), as a marker of the antioxidant defence, in 4 groups: group A - HCV positive patients with LP (n=12), group B - HCV positive patients without LP (n=12), group C - HCV negative patients with LP (n=31) and group D - control group (n=26). Results. In LP patients, we have identified an increased level of lipid peroxidation (4-HNE - group A - 8.41 +/- 1.11 mu g/mL, group B - 7.97 +/- 2.17 mu g/mL, group C - 7.81 +/- 1.96 mu g/mL and group D - 6.15 +/- 1.17 mu g/mL) and alterations in arginine methylation (SDMA - group A - 1.10 +/- 0.24 mu mol/L, group B - 1.03 +/- 0.16 mu mol/L, group C - 0.84 +/- 0.19 mu mol/L and group D - 0.50 +/- 0.06 mu mol/L) associated with a diminished antioxidant defence (TAC - group A - 234.50 +/- 49.96, mu mol/L group B - 255.83 +/- 41.41 mu mol/L, group C - 269.83 +/- 43.33 mu mol/L and group D - 316.46 +/- 29.33 mu mol/L), processes augmented by the association with HCV infection. Conclusion. There is an imbalance between oxidants and antioxidants in patients with LP, an imbalance that is augmented by the presence of HCV infection. SDMA could be regarded as a novel biomarker of oxidative stress among these patients. To the best of our knowledge this is the first study to investigate the influence of HCV infection on oxidative stress in LP patients.
引用
收藏
页码:359 / 368
页数:10
相关论文
共 50 条
[21]   The prevalence of hepatitis C virus infection in patients with lichen planus in Gaziantep region of Turkey [J].
Kirtak, N ;
Inalöz, HS ;
Özgöztasi, O ;
Erbagci, Z .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2000, 16 (12) :1159-1161
[22]   The prevalence of hepatitis C virus infection in patients with lichen planus in Gaziantep region of Turkey [J].
N. Kirtak ;
H.S. İnalöz ;
O. Özgöztaşi ;
Z. Erbağci .
European Journal of Epidemiology, 2000, 16 :1159-1161
[23]   Lichen planus and hepatitis C virus association: A meta-analysis study [J].
Rocha, Moises Rodrigues ;
Lins, Liliane ;
Cattony, Ana Carolina .
REVISTA PORTUGUESA DE ESTOMATOLOGIA MEDICINA DENTARIA E CIRURGIA MAXILOFACIAL, 2018, 59 (01) :2-9
[24]   A study on the association with hepatitis B and hepatitis C in 1557 patients with lichen planus [J].
Birkenfeld, S. ;
Dreiher, J. ;
Weitzman, D. ;
Cohen, A. D. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (04) :436-440
[25]   Association between hepatitis C virus and oral lichen planus [J].
Oliveira Alves, Monica Ghislaine ;
Almeida, Janete Dias ;
Guimaraes Cabral, Luiz Antonio .
HEPATITIS MONTHLY, 2011, 11 (02) :132-133
[26]   Hepatitis C virus and lichen planus in Nigerians: any relationship? [J].
Daramola, OOM ;
George, AO ;
Ogunbiyi, AO .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2002, 41 (04) :217-219
[27]   Lichen planus is not associated with hepatitis C virus infection in patients from north west England [J].
Tucker, SC ;
Coulson, IH .
ACTA DERMATO-VENEREOLOGICA, 1999, 79 (05) :378-379
[28]   Prevalence of hepatitis C virus antibodies and evaluation of hepatitis C virus genotypes in patients with lichen planus [J].
Imhof, M ;
Popal, H ;
Lee, JH ;
Zeuzem, S ;
MIlbradt, R .
DERMATOLOGY, 1997, 195 (01) :1-5
[29]   Lichen planus and hepatitis c virus (HCV)-there is no association:A serological case control study [J].
Adarsh Lata Singh ;
Sanjeev Chaudhary ;
ADSalodkar ;
SRJoharapurkar .
海南医学院学报, 2010, 16 (02) :154-156
[30]   Lichen planus and hepatitis C virus in the northern Kyushu region of Japan [J].
Nagao, Y ;
Sata, M ;
Tanikawa, K ;
Itoh, K ;
Kameyama, T .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1995, 25 (12) :910-914